Journal of Clinical Immunology

, Volume 31, Issue 2, pp 272–280

Clinical Aspects and Genetic Analysis of Taiwanese Patients with the Phenotype of Hyper-Immunoglobulin E Recurrent Infection Syndromes (HIES)

  • Wen-I Lee
  • Jing-Long Huang
  • Shy-Jae Lin
  • Kuo-Wei Yeh
  • Li-Chen Chen
  • Meng-Ying Hsieh
  • Yhu-Chering Huang
  • Ho-Chang Kuo
  • Kunder D. Yang
  • Hong-Ren Yu
  • Tang-Her Jaing
  • Chih-Hsun Yang
Article

Abstract

Background

Hyper-immunoglobulin E recurrent infection syndromes (HIES) has characteristic features and identified mutations. This study investigated clinical features and causal candidate mutations in Taiwanese patients with the HIES phenotype on referral base over 23 million inhabitants.

Patients and Methods

Clinical manifestations of the HIES phenotype, severity scoring, immunological functions and candidate genes of signal transducer and activator of transcription 3 (STAT3), tyrosine kinase 2 (TYKZ), and dedicator of cytokineses 8 (DOCK8) were analyzed.

Results

Between 1985 and 2009, six sporadic and two siblings met HIES criteria (onset age: 2–54 months; severity score: 31–65) out of 187 patients with primary immunodeficiencies. Five patients with the autosomal dominant (AD)-HIES phenotype presented as pneumatocoele, bronchiectasis, retained primary teeth, minor trauma fracture, scoliosis, coronary aneurysm, and lymphoma. Three with the autosomal recessive (AR)-HIES phenotype and impaired lymphocyte proliferation function had herpes simplex virus infection, molluscum contagiosum, and cerebral vasculitis. Notably in one patient with the AR-HIES phenotype, unintentional lead component in traditional application herbs for accelerating wound healing deposited in basal ganglia and aggravated involuntary movement relative to cerebral vacculitis. Those with mildly elevated memory T cells and decreased memory B cells trended to develop arteritis. Of five AD-HIES patients, three were mortalities from acute myocardial infarction, Proteus mirabilis, and Staphylococcus aureus sepsis. Only one had de novo novel STAT3 (Gln 469 Arg) mutation with “relative” lower HIES STAT3 score.

Conclusions

Known genetic defects responsible for the HIES phenotype are not so common in Taiwan. This may infer genetic variations in different ethnicities although selection bias and under-diagnosis for HIES with known genetic defects could be contribution factors.

Keywords

Hyper IgE recurrent infection syndrome (HIES) STAT3, TYK2, DOCK8, primary immunodeficiency diseases (PIDs) Taiwan Chinese molecular analysis 

References

  1. 1.
    Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692–702.PubMedCrossRefGoogle Scholar
  2. 2.
    Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144:93–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25:745–55.PubMedCrossRefGoogle Scholar
  4. 4.
    Davis SD, Schaller J, Wedgwood RJ. Job’s syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet. 1966;1:1013–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49:59–70.PubMedGoogle Scholar
  6. 6.
    Renner ED, Torgerson TR, Rylaarsdam S, Añover-Sombke S, Golob K, LaFlam T, et al. STAT3 mutation in the original patient with Job’s syndrome. N Engl J Med. 2007;357:1667–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.PubMedCrossRefGoogle Scholar
  8. 8.
    Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–919.PubMedCrossRefGoogle Scholar
  9. 9.
    Minegishi Y. Hyper-IgE syndrome. Curr Opin Immunol. 2009;21:487–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046–55.PubMedCrossRefGoogle Scholar
  11. 11.
    Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289–302.PubMedCrossRefGoogle Scholar
  12. 12.
    Minegishi Y, Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol. 2009;21:105–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Grimbacher B, Schäffer AA, Holland SM, Davis J, Gallin JI, Malech HL, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735–44.PubMedCrossRefGoogle Scholar
  14. 14.
    Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev. 2005;203:244–50.PubMedCrossRefGoogle Scholar
  15. 15.
    Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:424–32. e8.PubMedCrossRefGoogle Scholar
  16. 16.
    Lee WI, Kuo ML, Huang JL, Lin SJ, Wu CJ. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol. 2005;25:162–73.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee WI, Zhu Q, Gambineri E, Jin Y, Welcher AA, Ochs HD. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis. J Allergy Clin Immunol. 2003;112:958–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105:1881–90.PubMedCrossRefGoogle Scholar
  19. 19.
    Lee WI, Jaing TH, Hsieh MY, Kuo ML, Lin SJ, Huang JL. Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J Clin Immunol. 2006;26:274–83.PubMedCrossRefGoogle Scholar
  20. 20.
    Liang FC, Wei YC, Jiang TH, Hsiehi MY, Wen YC, Chiou YS, et al. Current classification and status of primary immunodeficiency diseases in Taiwan. Acta Paediatr Taiwan. 2008;49:3–8.PubMedGoogle Scholar
  21. 21.
    Schur PH. IgG subclasses—a review. Ann Allergy. 1987;58:89–96.PubMedGoogle Scholar
  22. 22.
    Dohil M, Prendiville JS. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr Dermatol. 1996;13:310–2.PubMedCrossRefGoogle Scholar
  23. 23.
    Kilic SS, Kilicbay F. Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome. Pediatrics. 2006;117:e1253–1255.PubMedCrossRefGoogle Scholar
  24. 24.
    Wolach B, Eliakim A, Pomeranz A, Cohen AH, Nusbacher J, Metzker A. Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet. 1996;347:67.PubMedCrossRefGoogle Scholar
  25. 25.
    Etzioni A, Shehadeh N, Brecher A, Yorman S, Pollack S. Cyclosporin A in hyperimmunoglobulin E syndrome. Ann Allergy Asthma Immunol. 1997;78:413–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Young TY, Jerome D, Gupta S. Hyperimmunoglobulinemia E syndrome associated with coronary artery aneurysms: deficiency of central memory CD4+ T cells and expansion of effector memory CD4+ T cells. Ann Allergy Asthma Immunol. 2007;98:389–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007;119:1234–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Nester TA, Wagnon AH, Reilly WF, Spitzer G, Kjeldsberg CR, Hill HR. Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med. 1998;105:162–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant. 2000;25:1303–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Goussetis E, Peristeri I, Kitra V, Traeger-Synodinos J, Theodosaki M, Psarra K, et al. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;126:392–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Gatz SA, Benninghoff U, Schütz C, Schulz A, Hönig M, Pannicke U, Holzmann KH, Schwarz K, Friedrich W. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant (2010) (in press)Google Scholar
  32. 32.
    Xie L, Hu X, Li Y, Zhang W, Chen L. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Clin Dev Immunol. 2010;2010:289873.PubMedCrossRefGoogle Scholar
  33. 33.
    Farkas LG. Anthropometry of the head and face in medicine. 2nd ed. New York: Raven Press; 1994. p. 286.Google Scholar
  34. 34.
    Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122:181–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Wen-I Lee
    • 1
    • 2
    • 9
  • Jing-Long Huang
    • 1
    • 2
  • Shy-Jae Lin
    • 2
  • Kuo-Wei Yeh
    • 2
  • Li-Chen Chen
    • 2
  • Meng-Ying Hsieh
    • 3
    • 4
  • Yhu-Chering Huang
    • 5
  • Ho-Chang Kuo
    • 7
  • Kunder D. Yang
    • 7
  • Hong-Ren Yu
    • 7
  • Tang-Her Jaing
    • 1
    • 6
  • Chih-Hsun Yang
    • 8
    • 9
  1. 1.Primary Immunodeficiency Care And Research (PICAR) InstituteChang Gung Memorial Hospital and University College of MedicineTaoyuanTaiwan
  2. 2.Department of Pediatric Allergy, Immunology and RheumatologyChang Gung Memorial Hospital and University College of MedicineTaoyuanTaiwan
  3. 3.Department of Pediatric NeurologyChang Gung Memory Hospital and University College of MedicineTaoyuanTaiwan
  4. 4.Graduate Institute of Medical ClinicsChang Gung Memory Hospital and University College of MedicineTaoyuanTaiwan
  5. 5.Department of Pediatric InfectionChang Gung Memorial Hospital and University College of MedicineTaoyuanTaiwan
  6. 6.Department of Pediatric Hematology and OncologyChang Gung Memorial Hospital and University College of MedicineTaoyuanTaiwan
  7. 7.Department of Pediatric Allergy, Immunology and RheumatologyChang Gung Memorial Hospital and University College of MedicineKaohsuingTaiwan
  8. 8.Department of DermatologyChang Gung Memorial Hospital and University College of MedicineTaoyuanTaiwan
  9. 9.Primary Immunodeficiency Care And Research (PICAR) InstituteChang Gung Memory Hospital and University College of MedicineTaoyuanTaiwan

Personalised recommendations